Ascendis Pharma A/S Announces Proposed Public Offering of ADSs
ASNDAscendis Pharma(ASND) GlobeNewswire News Room·2024-09-19 04:04

COPENHAGEN, Denmark, Sept. 18, 2024 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced that it has commenced an underwritten public offering of 300,000,000ofAmericanDepositaryShares(“ADSs”),eachofwhichrepresentsoneordinaryshareofAscendis.AlloftheADSsarebeingofferedbyAscendis.Inaddition,Ascendisexpectstogranttheunderwritersa30−dayoptiontopurchaseuptoanadditional300,000,000 of American Depositary Shares (“ADSs”), each of which represents one ordinary share of Ascendis. All of the ADSs are being offered by Ascendis. In addition, Ascendis expects to grant the underwriters a 30-day option to purchase up to an additional 45,000,000 of ADSs at the public offering price, less the underwriting commissions. Th ...